Differences in Humoral Immune Response against the Type 2 Porcine Reproductive and Respiratory Syndrome Virus via Different Immune Pathways

• Main Authors: Chen, J. (Author), Chen, Y. (Author), Cui, Z. (Author), Li, W. (Author), Sun, Y. (Author), Xia, P. (Author), Xu, P. (Author), Zhang, Y. (Author), Zhao, S. (Author)
• Format: Article
• Language: English
• Published: MDPI 2022
• Subjects: IgG; in vivo; mucosal immunity; NAs; PRRSV-2; SIgA; viremia
• Online Access: View Fulltext in Publisher

 The intramuscular vaccine is the principal strategy to protect pigs from porcine reproductive and respiratory syndrome virus (PRRSV), However, it is still difficult to control PRRSV effectively. This study infected piglets with PRRSV through intramuscular and intranasal inoculation. Subsequently, viral loads, anti-PRRSV antibody levels, and neutralizing antibodies (NAs) titers in both serum and saliva were monitored for 43 days. Meanwhile, tissues were obtained through necropsy at 43 days post-inoculation (dpi) to detect viral loads. The results indicated that viremia lasted from 3 to 31 dpi in both the inoculation groups, but the viruses survived in the lungs and lymph nodes after viremia clearance. The antibody response was detected from 11 dpi, but the response of NAs was delayed until 3–4 weeks. Furthermore, intranasal inoculation induced lower viral load levels than injection inoculation. In addition, positive SIgA and NAs levels were produced early, with higher levels through intranasal inoculation. Therefore, our data indicated that a more robust antibody response and lower virus loads could be induced by intranasal inoculation, and mucosal inoculation could be a suitable pathway for PRRSV vaccines. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.